In France the medication had been marketed as Mediator by Servier as an adjuvant antidiabetic; it was on the market between 1976 and 2009 and is thought to have caused between 500-2,000 deaths.
In France the medication had been marketed as by Laboratoires Servier as an adjuvant antidiabetic under the name Mediator. The drug was on the market between 1976 and 2009 and is thought to have caused between 500--2,000 deaths.